Loading…
Loading…
Formidable ETF (NYSEARCA:FORH - Get Free Report)'s share price fell 1.3% during mid-day trading on Thursday. The stock traded as low as $24.45 and last traded at $24.45. 14 shares traded hands during mid-day trading, a decline of 99% from the average session volume of 967 shares. The stock had previously closed at $24.78.
Formidable ETF (NYSEARCA:FORH - Get Free Report) shares traded down 1.3% during trading on Thursday. The company traded as low as $24.45 and last traded at $24.45. 14 shares traded hands during trading, a decline of 99% from the average session volume of 967 shares. The stock had previously closed at $24.78. Formidable ETF
China, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Shenzhen, JAN. 9, 2026 (GLOBE NEWSWIRE) In the third quarter of 2025, Li Auto (NYSE: LI; HKEX: 2015) recorded a net loss attributable to parent company shareholders of RMB 625 million (approximately USD 89.286 million), swinging to a loss on a year-over-year (YoY) basis and ending its streak of 11 consecutive profitable quarters.
REX Drone ETF (DRNZ) offers exposure to the rapidly growing global drone and unmanned systems market, with significant upside potential. I expect the drone sector to double by 2028, driven by military and commercial demand for advanced UAVs, counter-drones, and autonomous systems. DRNZ's portfolio blends smaller, drone-focused firms with major defense players, balancing growth potential and diversification.
Formidable ETF (NYSEARCA:FORH - Get Free Report)'s share price was up 0.3% on Thursday. The stock traded as high as $25.21 and last traded at $25.21. Approximately 36 shares were traded during mid-day trading, a decline of 98% from the average daily volume of 1,895 shares. The stock had previously closed at $25.13. Formidable
Lexicon Pharmaceuticals currently offers three late-stage assets - Zynquista, Inpefa, and pilavapadin - each with high-reward potential but significant regulatory and commercial risks. Zynquista's renewed FDA engagement for Type 1 diabetes could enable resubmission in early 2026, but commercial execution and reimbursement remain key hurdles. Inpefa's HCM Phase III readout is expected in Q1'27, yet LXRX's solo commercialization strategy is questionable without a partner or capital raise.
Agnico Eagle Mines Limited (AEM) delivers record Q3 2025 results, with strong operational performance and robust financials, amid a bullish gold market. AEM maintains steady production guidance, increased net cash, reduced long-term debt, and continues its long streak of dividend payments, reinforcing shareholder value. Technical indicators suggest recent correction may be over, providing headroom for AEM's rally to resume, though high gold prices could deter new investors.
Dutch Bros is outperforming the restaurant sector, gaining market share and accelerating traffic despite a tough consumer environment. Q2 showcased an acceleration to 4% traffic growth (the best reading in years), while Starbucks' traffic declined at -2% y/y in the North American segment. The company is set to launch a CPG line in 2026, presenting a significant new growth opportunity beyond its current in-café business.